To confirm whether ASR-600 affects other pro-survival signaling pathways apart from AR in CRPC, we examined AKT, mTOR, Estrogen receptor (ER), and Progesterone receptor (PR) expressions in prostate and breast cancer cell lines. The gene discussed is AR; the disease is breast cancer.